<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Noninsulinoma pancreatogenous hypoglycemia syndrome</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Noninsulinoma pancreatogenous hypoglycemia syndrome</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Noninsulinoma pancreatogenous hypoglycemia syndrome</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adrian Vella, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Irl B Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katya Rubinow, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) identifies a group of hyperinsulinemic hypoglycemic patients with unique clinical, diagnostic, surgical, and pathologic features [<a href="#rid1">1,2</a>]. These patients experience predominantly postprandial hypoglycemia and have abnormal islet morphology (predominantly islet cell hypertrophy), with no evidence of a functioning islet cell tumor.</p><p>The clinical manifestations, pathological findings, diagnosis, and treatment of NIPHS will be reviewed here. Other causes of hypoglycemia and how to differentiate among these causes are reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1763.html" rel="external">"Hypoglycemia in adults without diabetes mellitus: Clinical manifestations, causes, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1798.html" rel="external">"Hypoglycemia in adults without diabetes mellitus: Determining the etiology"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">DEFINITION</span><span class="headingEndMark"> — </span>Noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is a rare syndrome characterized by endogenous hyperinsulinemic hypoglycemia that is not caused by an insulinoma. Pancreatic specimens from such patients show beta cell hypertrophy, islets with enlarged and hyperchromatic nuclei, and increased islets budding from periductular epithelium [<a href="#rid1">1-3</a>]. Previously, these histologic findings have been considered characteristic of nesidioblastosis, a term that refers to neoformation of islets of Langerhans from pancreatic duct epithelium [<a href="#rid4">4</a>]. However, it is clear that these appearances can be seen in asymptomatic individuals, and the term "nesidioblastosis" should be utilized to describe the histologic appearance and not necessarily imply islet dysfunction [<a href="#rid5">5</a>].</p><p>Formal epidemiologic studies have not been conducted for NIPHS; however, the condition appears to be even rarer than insulinoma. For example, during the period from 1996 to 2004, 20 patients with NIPHS (16 male, 4 female) and 118 patients with insulinoma (51 male, 67 female) were surgically confirmed at the Mayo Clinic [<a href="#rid1">1,2,6</a>].</p><p>Although the underlying pathologic features of NIPHS and post-gastric bypass hypoglycemia initially were thought to be similar, post-gastric bypass hypoglycemia should be considered a separate clinical entity that occurs after Roux-en-Y gastric bypass or similar procedures that result in substantial weight loss and disrupt the regulation of gastric emptying [<a href="#rid7">7</a>]. (See <a class="local">'Hypoglycemia abnormalities after Roux-en-Y gastric bypass surgery'</a> below and  <a class="medical medical_review" href="/z/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Postprandial hyperinsulinemic hypoglycemia'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H4"><span class="h2">Symptoms</span><span class="headingEndMark"> — </span>The predominant clinical feature of noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is postprandial hypoglycemia with adrenergic (eg, tachycardia, tremor) and neuroglycopenic (eg, confusion, seizure, or dysarthria) symptoms. Patients may have neuroglycopenic symptoms without adrenergic symptoms.</p><p>In a series of 10 patients from the Mayo Clinic, age range 16 to 78 years old, mean body mass index (BMI) 25.7 kg/m<sup>2</sup>, with a male predominance (70 percent), symptoms occurred postprandially, two to four hours after meals, and only rarely while fasting [<a href="#rid1">1,2,8</a>]. All patients had neuroglycopenic symptoms, and several lost consciousness or had generalized seizures. Forty percent of the patients had a history of upper gastrointestinal surgery (not gastric bypass) [<a href="#rid6">6</a>]. In smaller series and case reports, a similar preponderance of postprandial hypoglycemia, neuroglycopenic symptoms, and male predominance was noted [<a href="#rid9">9-16</a>]. However, fasting hypoglycemia has also been reported [<a href="#rid15">15,17,18</a>].</p><p>In contrast, most patients with insulinomas have fasting hypoglycemia. Although they may occasionally also have postprandial symptoms, the occurrence of symptoms solely postprandially is rare (approximately 5 percent of patients). (See  <a class="medical medical_review" href="/z/d/html/2187.html" rel="external">"Insulinoma", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Biochemical findings</span><span class="headingEndMark"> — </span>During episodes of hypoglycemia, patients with NIPHS have biochemical findings similar to those of insulinoma, including elevated plasma insulin, C-peptide, and proinsulin concentrations; low plasma beta-hydroxybutyrate; and a negative sulfonylurea/meglitinide screen (<a class="graphic graphic_table graphicRef56314" href="/z/d/graphic/56314.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H20267827"><span class="h2">Histopathology</span><span class="headingEndMark"> — </span>Histopathology descriptions of excised pancreatic tissue include islet cell hypertrophy with enlarged and hyperchromatic nuclei, sometimes islet cell hyperplasia, and increased periductular islets [<a href="#rid1">1,3,10</a>]. Islet-like cells budding off exocrine ducts have been noted and were most evident on immunohistochemical staining for chromogranin A (<a class="graphic graphic_picture graphicRef51119" href="/z/d/graphic/51119.html" rel="external">picture 1</a>) [<a href="#rid1">1</a>]. The hypertrophic islet cells also stained positively for insulin, glucagon, somatostatin, and pancreatic polypeptide [<a href="#rid1">1,11</a>]. The distribution of the hormones within the islets was normal, with between 60 to 80 percent of the islet cells staining for insulin. Many of the cells budding off ducts also contained insulin.</p><p>This constellation of pathological changes, including primary islet cell hypertrophy and neodifferentiation of islet of Langerhans cells from pancreatic duct epithelium, is similar to that observed in infants with persistent hyperinsulinemic hypoglycemia [<a href="#rid4">4,19,20</a>] and less often in adults [<a href="#rid3">3,21-27</a>]. These pathology findings have also been described in nontumor pancreatic tissue of patients with insulinomas [<a href="#rid28">28,29</a>]; in patients with type 2 diabetes previously treated with insulin [<a href="#rid24">24,30</a>] or a sulfonylurea [<a href="#rid31">31</a>]; and in patients with other islet cell tumors, such as gastrinomas [<a href="#rid32">32</a>] or multiple endocrine neoplasia type 1 [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/z/d/html/5810.html" rel="external">"Pathogenesis, clinical presentation, and diagnosis of congenital hyperinsulinism"</a>.)</p><p>These pathology findings probably correlate with the clinical features of the syndrome of hyperinsulinemic hypoglycemia. The presence of these findings in an individual with a hypoglycemic syndrome does not necessarily exclude an islet cell tumor [<a href="#rid34">34</a>]. In addition, subtle histologic changes referred to as nesidioblastosis have been observed in 36 percent of patients in an autopsy series of 207 patients with no history of hypoglycemia [<a href="#rid5">5</a>]. It is important to ensure that functional abnormalities, specifically, autonomous insulin secretion causing hypoglycemia, are present before embarking on surgery (see <a class="local">'Diagnostic evaluation'</a> below). Surgery and histopathology are important for ensuring that abnormalities, if present, are focal and not diffuse.</p><p>In an analysis of pancreatic tissue from 36 cases (27 post-gastric bypass) of nesidioblastosis, increased insulin-like growth factor-2, insulin-like growth factor-1 receptor alpha, and transforming growth factor receptor beta 3 expression were noted in the islets of patients compared with controls who had benign exocrine pancreatic tumors [<a href="#rid8">8</a>]. These findings suggest a role for growth factors in driving the structural changes observed in adults.</p><p class="headingAnchor" id="H5855575"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="headingAnchor" id="H3182145456"><span class="h2">Insulinoma</span><span class="headingEndMark"> — </span>Adults with endogenous hyperinsulinism and negative screens for sulfonylurea/meglitinide and insulin antibodies, are most likely to have an insulinoma. It is usually not difficult to distinguish insulinoma from noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS), considering the timing of symptoms (typically fasting for insulinoma and postprandial for NIPHS), sex preference (male predominance for NIPHS), and, ultimately, the results of localization studies. With appropriate preoperative localization studies plus intraoperative ultrasonography and palpation, a tumor (or tumors) can be identified in 98 percent of patients with insulinomas. It is important to remember, however, that rare cases of insulinoma may have postprandial hypoglycemia [<a href="#rid35">35</a>] and rare cases of NIPHS may have fasting hypoglycemia [<a href="#rid10">10,17,21,36</a>]. (See  <a class="medical medical_review" href="/z/d/html/1798.html" rel="external">"Hypoglycemia in adults without diabetes mellitus: Determining the etiology", section on 'C-peptide level ≥0.2 mmol/L'</a> and  <a class="medical medical_review" href="/z/d/html/2187.html" rel="external">"Insulinoma"</a>.)</p><p class="headingAnchor" id="H5855587"><span class="h2">Hypoglycemia abnormalities after Roux-en-Y gastric bypass surgery</span><span class="headingEndMark"> — </span>Although endogenous hyperinsulinemic hypoglycemia is rare, there have been case reports of it occurring after Roux-en-Y gastric bypass (RYGB) surgery [<a href="#rid37">37-40</a>]. Hypoglycemia following RYGB and NIPHS have some features in common (eg, postprandial hyperinsulinemic hypoglycemia, negative radiologic localization and positive calcium stimulation test), but they appear to be distinct diseases [<a href="#rid7">7</a>]. Patients with NIPHS have never undergone gastric bypass or other upper gastrointestinal tract surgery and they are predominantly male, as opposed to the female predominance for post-gastric bypass hypoglycemia. (See  <a class="medical medical_review" href="/z/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Postprandial hyperinsulinemic hypoglycemia'</a>.)</p><p>In the initial series of hypoglycemia after RYGB, six patients were described with symptomatic postprandial hypoglycemia (symptoms of confusion, tunnel vision, and loss of consciousness occurring one to three hours after eating) six months to eight years following RYGB [<a href="#rid37">37</a>], five had evidence of islet cell hyperplasia, and one had both islet cell hyperplasia and evidence of a multifocal insulinoma. Patients with severe postprandial hypoglycemia and pancreatic islet hyperplasia after RYGB have also been reported from other institutions [<a href="#rid38">38-40</a>]. However, it is important to remember there is no consensus as to how to define islet cell hyperplasia in these situations, leading to disagreement as to the significance of islet morphology in the post-RYGB setting [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H666059"><span class="h2">Dumping syndrome</span><span class="headingEndMark"> — </span>Dumping syndrome, which should be differentiated from hypoglycemia, can occur after gastric bypass surgery, particularly when high levels of simple carbohydrates are ingested. It is characterized by postprandial diaphoresis, weakness, dizziness, and palpitations due to intravascular volume contraction. Although these "adrenergic" symptoms are easily (and often) attributed to hypoglycemia, glucose is not low. In patients with dumping syndrome, symptoms can occur within 15 to 30 minutes of a meal and the plasma glucose can be normal when symptoms are present. Symptoms do not respond to carbohydrate ingestion and patients often express symptoms of fatigue and somnolence after such episodes [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/1769.html" rel="external">"Evaluation of postprandial symptoms of hypoglycemia in adults without diabetes", section on 'Alimentary hypoglycemia'</a>.)</p><p class="headingAnchor" id="H20268413"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>The diagnostic approach to hypoglycemia is reviewed briefly below and in more detail separately. Findings on pathology should ultimately confirm the presence of abnormal islet structure in patients with noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) and is only rarely described as a concomitant finding in patients with insulinoma [<a href="#rid28">28,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/1798.html" rel="external">"Hypoglycemia in adults without diabetes mellitus: Determining the etiology", section on 'Supervised testing'</a>.)</p><p class="headingAnchor" id="H1423373789"><span class="h2">Laboratory evaluation</span></p><p class="bulletIndent1"><span class="glyph">●</span>The initial evaluation of hypoglycemia includes measurement of glucose, insulin, proinsulin, C-peptide, beta-hydroxybutyrate, and sulfonylurea/meglitinide screening during an episode of hypoglycemia (<a class="graphic graphic_table graphicRef56314" href="/z/d/graphic/56314.html" rel="external">table 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with endogenous hyperinsulinism, insulin antibodies should be measured to distinguish insulin autoimmune hypoglycemia from other causes of hyperinsulinism. Insulin antibodies do not need to be drawn during hypoglycemia.</p><p></p><p class="headingAnchor" id="H5854725"><span class="h2">Localization studies</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transabdominal ultrasound</strong> – In patients with endogenous hyperinsulinemic hypoglycemia (and negative screens for sulfonylurea/meglitinide and insulin antibodies), localization studies are necessary to distinguish between the presence of an insulinoma versus a diffuse process (islet cell hyperplasia). The choice of localization procedure depends upon which tests are available and local radiologic skill. Transabdominal ultrasonography is our preferred initial test for the identification of an insulinoma. (See  <a class="medical medical_review" href="/z/d/html/2187.html" rel="external">"Insulinoma", section on 'Tumor localization'</a>.)</p><p></p><p class="bulletIndent1">Several noninvasive procedures are available, including computed tomography (CT), magnetic resonance imaging (MRI), transabdominal ultrasonography, 111-In-pentetreotide imaging, and fluorine-18-L-dihydroxyphenylalanine positron emission tomography (18F-DOPA PET). Radiological localization studies are negative for insulinoma in patients with NIPHS. In the Mayo series, as an example, all radiologic studies (transabdominal ultrasonography, triple phase CT, celiac axis angiography, and intraoperative ultrasonography) were negative for insulinoma [<a href="#rid1">1</a>]. The sensitivity of each of these preoperative studies is only approximately 50 to 60 percent, but their combined sensitivity is significantly higher. Endoscopic ultrasound is an invasive imaging study that is often utilized when initial noninvasive imaging studies are negative. It is a procedure that is operator dependent but has good sensitivity for the detection of islet cell tumors [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>When imaging is negative: SACST</strong> – In patients with complex cases of endogenous hyperinsulinemic hypoglycemia and negative radiologic localization studies, a selective arterial calcium stimulation test (SACST) with hepatic venous sampling should be performed to establish that the hyperinsulinemia has a pancreatic origin and, in addition, its regionality within the pancreas. This procedure is important to perform in cases where pancreatic exploration is considered, and it should be conducted by an interventional radiologist skilled in cannulating intraabdominal vessels. The patient may have to be referred to a tertiary center.</p><p></p><p class="bulletIndent1">A SACST involves injections of <a class="drug drug_general" data-topicid="9190" href="/z/d/drug information/9190.html" rel="external">calcium gluconate</a>, an insulin secretagogue, into arteries supplying the pancreas with subsequent sampling of the right hepatic venous effluent for insulin [<a href="#rid43">43,44</a>]. A positive result is defined as a doubling or tripling of the basal hepatic venous serum insulin concentration. The increase in insulin occurs in samples from the artery supplying the region with hyperfunctioning islets, either an insulinoma or islet hypertrophy, which facilitates operative localization.</p><p></p><p class="bulletIndent1">In patients with NIPHS, positive responses are usually observed after injection of multiple arteries, in contrast to insulinoma where the response is positive in one artery alone, unless the tumor resides in an area fed by two arteries or the patient has multiple insulinomas scattered throughout the pancreas [<a href="#rid1">1</a>]. Thus, focal versus diffuse positivity does not provide incontrovertible evidence for or against insulinoma/NIPHS, since insulinoma may be multiple and NIPHS may be caused by focal pathology. The magnitude of the response, however, may differ from that observed in insulinoma [<a href="#rid45">45</a>]. (See  <a class="medical medical_review" href="/z/d/html/2187.html" rel="external">"Insulinoma", section on 'Tumor localization'</a> and  <a class="medical medical_review" href="/z/d/html/2612.html" rel="external">"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine neoplasms"</a>.)</p><p></p><p class="headingAnchor" id="H9"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H10"><span class="h2">Mild to moderate symptoms</span><span class="headingEndMark"> — </span>For patients with noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS), nutritional modification is a reasonable initial intervention. Nutritional modification includes reduction of free carbohydrate intake and spacing carbohydrate intake evenly throughout the day. It has been reported to reduce postprandial glycemic excursions and mild symptoms of hypoglycemia in some patients with post-bypass postprandial hypoglycemia [<a href="#rid39">39,46</a>].</p><p>If mild to moderate symptoms persist patients with NIPHS, we prescribe <a class="drug drug_general" data-topicid="9219" href="/z/d/drug information/9219.html" rel="external">acarbose</a> (initial dose 25 mg three times daily, with each main meal). The dose can be advanced to the point of balance between tolerance and benefit, not to exceed 100 mg three times/day. Success with this approach avoids surgery.</p><p>In case reports, <a class="drug drug_general" data-topicid="9714" href="/z/d/drug information/9714.html" rel="external">octreotide</a>, <a class="drug drug_general" data-topicid="10043" href="/z/d/drug information/10043.html" rel="external">verapamil</a>, <a class="drug drug_general" data-topicid="9346" href="/z/d/drug information/9346.html" rel="external">diazoxide</a>, and <a class="drug drug_general" data-topicid="9219" href="/z/d/drug information/9219.html" rel="external">acarbose</a> have reportedly improved hypoglycemic symptoms in patients with post-gastric bypass hypoglycemia or, in fewer reports, NIPHS [<a href="#rid39">39,47-50</a>]. The evaluation of the post-gastric bypass patients did not always include careful documentation of postprandial hyperinsulinemic hypoglycemia.</p><p class="headingAnchor" id="H335477"><span class="h2">Severe or refractory symptoms</span><span class="headingEndMark"> — </span>For patients with NIPHS and severe postprandial hypoglycemia (eg, neuroglycopenia with loss of consciousness) or with symptoms refractory to medical management, surgery is the mainstay of therapy. In case series and reports, partial or subtotal pancreatectomy successfully relieved hypoglycemic symptoms in the majority of patients with NIPHS and nesidioblastosis [<a href="#rid1">1,2,15,26,27</a>].</p><p>The degree of surgery is determined by the results of the selective arterial calcium stimulation test (SACST). The pancreas to the left of the superior mesenteric vein is resected when the SACST is positive only after splenic artery injection, and the resection is extended to the right of the superior mesenteric vein when the test is positive after injection of an additional artery. The pancreas can be debulked in a gradient-guided fashion, even in patients whose disease appears to involve the whole pancreas.</p><p class="headingAnchor" id="H665809"><span class="h2">Recurrent symptoms</span><span class="headingEndMark"> — </span>Recurrent hypoglycemia after partial pancreatectomy has been observed in NIPHS. Since the symptoms are usually mild when they recur, lifestyle modification or medical management may suffice. Only rarely has completion pancreatectomy been conducted for NIPHS [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H936943346"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112842.html" rel="external">"Society guideline links: Hypoglycemia in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/111962.html" rel="external">"Society guideline links: Well-differentiated gastroenteropancreatic neuroendocrine tumors"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition</strong> – Noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS) is a syndrome characterized by endogenous hyperinsulinemic hypoglycemia that is not caused by an insulinoma. Pancreatic specimens from such patients show abnormal islet architecture. (See <a class="local">'Definition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The predominant clinical feature of NIPHS is postprandial hypoglycemia and the presence of neuroglycopenic symptoms. During episodes of hypoglycemia, patients with NIPHS have biochemical findings similar to those of insulinoma, including elevated plasma insulin, C-peptide, and proinsulin concentrations; low plasma beta-hydroxybutyrate; and a negative sulfonylurea/meglitinide screen (<a class="graphic graphic_table graphicRef56314" href="/z/d/graphic/56314.html" rel="external">table 1</a>). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – In adults, hypoglycemia due to endogenous hyperinsulinism, with negative screens for sulfonylurea/meglitinide and insulin antibodies, can be caused by a beta cell tumor (eg, insulinoma) or a functional beta cell disorder (eg, NIPHS, post-gastric bypass hypoglycemia). Although hypoglycemia following Roux-en-Y gastric bypass (RYGB) and NIPHS have some features in common (eg, postprandial hyperinsulinemic hypoglycemia, negative radiologic localization but positive calcium stimulation test, and, perhaps, histologic findings), they appear to be distinct diseases. (See <a class="local">'Differential diagnosis'</a> above and <a class="local">'Hypoglycemia abnormalities after Roux-en-Y gastric bypass surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Localization studies</strong> – In patients with endogenous hyperinsulinemic hypoglycemia (and negative screens for sulfonylurea/meglitinide and insulin antibodies), localization studies (eg, transabdominal ultrasound) are necessary to distinguish between the presence of an insulinoma versus a diffuse process (islet cell hyperplasia). Radiological localization studies are negative in patients with NIPHS and typically positive in patients with insulinoma. When radiologic localization studies are negative, a selective arterial calcium stimulation test (SACST) with hepatic venous sampling should be performed to establish that the hyperinsulinemia has a pancreatic origin and, in addition, its regionality within the pancreas. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent1">The diagnosis of NIPHS may then be confirmed when pancreatic specimens from such patients show beta cell hypertrophy, islets with enlarged and hyperchromatic nuclei, and increased periductular islets. (See <a class="local">'Diagnostic evaluation'</a> above and <a class="local">'Histopathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – For patients with mild to moderate symptoms, dietary modification (low carbohydrate diet) is a reasonable initial intervention. Those patients that are refractory to a low carbohydrate diet may respond to an alpha-glucosidase inhibitor (eg, <a class="drug drug_general" data-topicid="9219" href="/z/d/drug information/9219.html" rel="external">acarbose</a>).</p><p></p><p class="bulletIndent1">For patients with persistent symptoms despite medical therapy, or for patients with severe hypoglycemia (neuroglycopenia with loss of consciousness), graded pancreatectomy is required to control symptoms. (See <a class="local">'Treatment'</a> above.) </p><p></p><p class="headingAnchor" id="H2355916362"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges F John Service, MD, PhD, now deceased, who contributed to an earlier version of this topic.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Service FJ, Natt N, Thompson GB, et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab 1999; 84:1582.</a></li><li><a class="nounderline abstract_t">Thompson GB, Service FJ, Andrews JC, et al. Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients. Surgery 2000; 128:937.</a></li><li><a class="nounderline abstract_t">Anlauf M, Wieben D, Perren A, et al. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol 2005; 29:524.</a></li><li><a class="nounderline abstract_t">Laidlaw GF. Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 1938; 2:125.</a></li><li><a class="nounderline abstract_t">Karnauchow PN. Nesidioblastosis in adults without insular hyperfunction. Am J Clin Pathol 1982; 78:511.</a></li><li><a class="nounderline abstract_t">Vanderveen KA, Grant CS, Thompson GB, et al. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery 2010; 148:1237.</a></li><li><a class="nounderline abstract_t">Salehi M, Vella A, McLaughlin T, Patti ME. Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies. J Clin Endocrinol Metab 2018; 103:2815.</a></li><li><a class="nounderline abstract_t">Rumilla KM, Erickson LA, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol 2009; 22:239.</a></li><li><a class="nounderline abstract_t">Kenney B, Tormey CA, Qin L, et al. Adult nesidioblastosis. Clinicopathologic correlation between pre-operative selective arterial calcium stimulation studies and post-operative pathologic findings. JOP 2008; 9:504.</a></li><li><a class="nounderline abstract_t">Won JG, Tseng HS, Yang AH, et al. Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS). Clin Endocrinol (Oxf) 2006; 65:566.</a></li><li><a class="nounderline abstract_t">Sahloul R, Yaqub N, Driscoll HK, et al. Noninsulinoma pancreatogenous hypoglycemia syndrome: quantitative and immunohistochemical analyses of islet cells for insulin, glucagon, somatostatin, and pancreatic and duodenal homeobox protein. Endocr Pract 2007; 13:187.</a></li><li><a class="nounderline abstract_t">Hong R, Choi DY, Lim SC. Hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report. World J Gastroenterol 2008; 14:140.</a></li><li><a class="nounderline abstract_t">Tsujino M, Sugiyama T, Nishida K, et al. Noninsulinoma pancreatogenous hypoglycemia syndrome: a rare case of adult-onset nesidioblastosis. Intern Med 2005; 44:843.</a></li><li><a class="nounderline abstract_t">Kim HK, Shong YK, Han DJ, et al. Nesidioblastosis in an adult with hyperinsulinemic hypoglycemia. Endocr J 1996; 43:163.</a></li><li><a class="nounderline abstract_t">Starke A, Saddig C, Kirch B, et al. Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome. World J Surg 2006; 30:670.</a></li><li><a class="nounderline abstract_t">McElroy MK, Lowy AM, Weidner N. Case report: focal nesidioblastosis ("nesidioblastoma") in an adult. Hum Pathol 2010; 41:447.</a></li><li><a class="nounderline abstract_t">Nathan DM, Axelrod L, Proppe KH, et al. Nesidioblastosis associated with insulin-mediated hypoglycemia in an adult. Diabetes Care 1981; 4:383.</a></li><li><a class="nounderline abstract_t">McHenry C, Newell K, Chejfec G, et al. Adult nesidioblastosis. An unusual cause of fasting hypoglycemia. Am Surg 1989; 55:366.</a></li><li><a class="nounderline abstract_t">de Lonlay P, Fournet JC, Rahier J, et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997; 100:802.</a></li><li><a class="nounderline abstract_t">de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999; 340:1169.</a></li><li><a class="nounderline abstract_t">Walmsley D, Matheson NA, Ewen S, et al. Nesidioblastosis in an elderly patient. Diabet Med 1995; 12:542.</a></li><li><a class="nounderline abstract_t">Tibaldi JM, Lorber D, Lomasky S, et al. Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas. J Surg Oncol 1992; 50:53.</a></li><li><a class="nounderline abstract_t">Burman WJ, McDermott MT, Bornemann M. Familial hyperinsulinism presenting in adults. Arch Intern Med 1992; 152:2125.</a></li><li><a class="nounderline abstract_t">Bell DS, Grizzle WE, Dunlap NE. Nesidioblastosis causing reversal of insulin-dependent diabetes and development of hyperinsulinemic hypoglycemia. Diabetes Care 1995; 18:1379.</a></li><li><a class="nounderline abstract_t">Carlson T, Eckhauser ML, DeBaz B, et al. Nesidioblastosis in an adult: an illustrative case and collective review. Am J Gastroenterol 1987; 82:566.</a></li><li><a class="nounderline abstract_t">Raffel A, Krausch M M, Anlauf M, et al. Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge. Surgery 2007; 141:179.</a></li><li><a class="nounderline abstract_t">Toyomasu Y, Fukuchi M, Yoshida T, et al. Treatment of hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report. Am Surg 2009; 75:331.</a></li><li><a class="nounderline abstract_t">Campbell IL, Harrison LC, Ley CJ, et al. Nesidioblastosis and multifocal pancreatic islet cell hyperplasia in an adult. Clinicopathologic features and in vitro pancreatic studies. Am J Clin Pathol 1985; 84:534.</a></li><li><a class="nounderline abstract_t">Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1983. A 37-year-old schizophrenic woman with hypoglycemic episode. N Engl J Med 1983; 308:30.</a></li><li><a class="nounderline abstract_t">Sandler R, Horwitz DL, Rubenstein AH, Kuzuya H. Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. Am J Med 1975; 59:730.</a></li><li><a class="nounderline abstract_t">Rayman G, Santo M, Salomon F, et al. Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis. J Clin Pathol 1984; 37:651.</a></li><li><a class="nounderline abstract_t">Farley DR, van Heerden JA, Myers JL. Adult pancreatic nesidioblastosis. Unusual presentations of a rare entity. Arch Surg 1994; 129:329.</a></li><li><a class="nounderline abstract_t">Thompson NW, Lloyd RV, Nishiyama RH, et al. MEN I pancreas: a histological and immunohistochemical study. World J Surg 1984; 8:561.</a></li><li><a class="nounderline abstract_t">Goudswaard WB, Houthoff HJ, Koudstaal J, Zwierstra RP. Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon. Hum Pathol 1986; 17:46.</a></li><li><a class="nounderline abstract_t">Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 2009; 94:1069.</a></li><li><a class="nounderline abstract_t">Albers N, Löhr M, Bogner U, et al. Nesidioblastosis of the pancreas in an adult with persistent hyperinsulinemic hypoglycemia. Am J Clin Pathol 1989; 91:336.</a></li><li><a class="nounderline abstract_t">Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353:249.</a></li><li><a class="nounderline abstract_t">Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005; 48:2236.</a></li><li><a class="nounderline abstract_t">Goldfine AB, Mun E, Patti ME. Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity. Curr Opin Endocrinol Diabetes Obes 2006; 13:419.</a></li><li><a class="nounderline abstract_t">Clancy TE, Moore FD Jr, Zinner MJ. Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg 2006; 10:1116.</a></li><li><a class="nounderline abstract_t">Meier JJ, Butler AE, Galasso R, Butler PC. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. Diabetes Care 2006; 29:1554.</a></li><li><a class="nounderline abstract_t">Tack J, Arts J, Caenepeel P, et al. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009; 6:583.</a></li><li><a class="nounderline abstract_t">Doppman JL, Chang R, Fraker DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 1995; 123:269.</a></li><li><a class="nounderline abstract_t">O'Shea D, Rohrer-Theurs AW, Lynn JA, et al. Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab 1996; 81:1623.</a></li><li><a class="nounderline abstract_t">Thompson SM, Vella A, Thompson GB, et al. Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis. J Clin Endocrinol Metab 2015; 100:4189.</a></li><li><a class="nounderline abstract_t">Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis 2008; 4:492.</a></li><li><a class="nounderline abstract_t">Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia. Obes Surg 2009; 19:1333.</a></li><li><a class="nounderline abstract_t">Moreira RO, Moreira RB, Machado NA, et al. Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose. Obes Surg 2008; 18:1618.</a></li><li><a class="nounderline abstract_t">Arao T, Okada Y, Hirose A, Tanaka Y. A rare case of adult-onset nesidioblastosis treated successfully with diazoxide. Endocr J 2006; 53:95.</a></li><li><a class="nounderline abstract_t">Nadelson J, Epstein A. A rare case of noninsulinoma pancreatogenous hypoglycemia syndrome. Case Rep Gastrointest Med 2012; 2012:164305.</a></li></ol></div><div id="topicVersionRevision">Topic 1782 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10323384" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11114627" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15767809" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Nesidioblastoma, the islet tumor of the pancreas</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6753563" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Nesidioblastosis in adults without insular hyperfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21134557" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30101281" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18931647" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18648143" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Adult nesidioblastosis. Clinicopathologic correlation between pre-operative selective arterial calcium stimulation studies and post-operative pathologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17054456" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17490935" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Noninsulinoma pancreatogenous hypoglycemia syndrome: quantitative and immunohistochemical analyses of islet cells for insulin, glucagon, somatostatin, and pancreatic and duodenal homeobox protein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18176978" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16157984" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Noninsulinoma pancreatogenous hypoglycemia syndrome: a rare case of adult-onset nesidioblastosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8793331" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Nesidioblastosis in an adult with hyperinsulinemic hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16555022" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20004945" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Case report: focal nesidioblastosis ("nesidioblastoma") in an adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6284461" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Nesidioblastosis associated with insulin-mediated hypoglycemia in an adult.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2729774" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Adult nesidioblastosis. An unusual cause of fasting hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9259578" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10202168" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical features of 52 neonates with hyperinsulinism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7648830" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Nesidioblastosis in an elderly patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1573895" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1358043" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Familial hyperinsulinism presenting in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8721942" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Nesidioblastosis causing reversal of insulin-dependent diabetes and development of hyperinsulinemic hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3578240" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Nesidioblastosis in an adult: an illustrative case and collective review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17263973" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19385295" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Treatment of hyperinsulinemic hypoglycemia due to diffuse nesidioblastosis in adults: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2863976" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Nesidioblastosis and multifocal pancreatic islet cell hyperplasia in an adult. Clinicopathologic features and in vitro pancreatic studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6292720" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1983. A 37-year-old schizophrenic woman with hypoglycemic episode.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1200040" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6373837" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8129611" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Adult pancreatic nesidioblastosis. Unusual presentations of a rare entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6207668" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : MEN I pancreas: a histological and immunohistochemical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2867969" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19141587" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2646913" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Nesidioblastosis of the pancreas in an adult with persistent hyperinsulinemic hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16034010" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16195867" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16966030" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16801578" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19724252" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Pathophysiology, diagnosis and management of postoperative dumping syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7611592" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8636378" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Localization of insulinomas by selective intraarterial calcium injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26312578" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Selective Arterial Calcium Stimulation With Hepatic Venous Sampling Differentiates Insulinoma From Nesidioblastosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18656831" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19551453" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18566871" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16543678" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A rare case of adult-onset nesidioblastosis treated successfully with diazoxide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23213581" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A rare case of noninsulinoma pancreatogenous hypoglycemia syndrome.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
